Two More Compounders Warned for Poor Sterile Drug Manufacturing

Drug Industry Daily
A A
Compounding pharmacies continue to be plagued by sterility issues, as the FDA handed warning letters to facilities in Florida and Kentucky — bringing to nine the number of compounders cited for such deficiencies since October.

To View This Article:

Login

Subscribe To Drug Industry Daily